Ticarcillin/clavulanic acid
| Combination of | |
|---|---|
| Ticarcillin | β-lactam antibiotic |
| Clavulanic acid | β-lactamase inhibitor |
| Clinical data | |
| Trade names | Co-ticarclav |
Ticarcillin/clavulanic acid, or co-ticarclav, is a combination antibiotic consisting of ticarcillin, a β-lactam antibiotic, and clavulanic acid, a β-lactamase inhibitor. This combination results in an antibiotic with an increased spectrum of action and restored efficacy against ticarcillin-resistant bacteria that produce certain β-lactamases.[1]
References
- ↑ GlaxoSmithKline. Date of Revision: February 7, 2014 TIMENTIN Product Monograph
This article is issued from Wikipedia - version of the Tuesday, August 11, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.